GRL-03022
GRL-03022 is a potent, selective and non-covalent G protein-coupled receptor kinase 5 (GRK5) inhibitor with an IC50 of 60 nM. GRL-03022 exhibits >16000-fold selectivity over GRK2 (IC50 > 1000 μM) . GRL-03022 can be used for heart failure and cancer research[1].
Product Specifications
UNSPSC
12352005
Target
G Protein-coupled Receptor Kinase (GRK)
Related Pathways
GPCR/G Protein
Field of Research
Cancer; Cardiovascular Disease
Smiles
O=C(C1=CC2=C(NC(/C2=C\C3=C(C)C(C(N[C@@H](C)COC)=O)=C(C)N3)=O)C=C1)N[C@@H](C4=CC=CC=C4)C
Molecular Formula
C29H32N4O4
Molecular Weight
500.59
References & Citations
[1]Ghosh AK, et al. Potent, Selective, and Drug-Like G Protein-Coupled Receptor Kinase 5 and 6 Inhibitors: Design, Synthesis, and X-Ray Structural Studies. ChemMedChem. 2025 Oct 15;20 (20) :e202500257.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Isoform
GRK2; GRK5
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
![Rac-2-[ (1R,2S) -2-Phenylcyclopropyl]acetic acid](https://cdn.genprice.uk/genprice/uk/genprice3.webp)
